![]() ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases. | ![]() Amoy Diagnostics Amoy Diagnostics (AmoyDx, 厦门艾德生物医药科技股份有限公司) is a company that provides molecular diagnostic products and services for oncology precision medicine. | ![]() Berry Genomics Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications, primarily in genetic testing and oncology testing. | |
Founding Date | Founding Date 2014 | Founding Date 2008 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations CN HQ Suzhou, CN Hong Kong, HK Taipei, TW Cambridge, US Menlo Park, US | Locations Xiamen, CN HQ Singapore, SG | Locations CN HQ |
Employees | Employees 1,869 | Employees 1,144 | Employees 1,402 |
Valuation ($) | Valuation ($) 3.2 b | Valuation ($) 1.3 b | Valuation ($) 460.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) $460.2m (FY, 2025) | Revenue (est.) ¥1.2b (FY, 2025) | Revenue (est.) ¥1b (FY, 2024) |
Cost of goods | Cost of goods $190.5m (FY, 2025) | Cost of goods ¥208.5m (FY, 2025) | Cost of goods ¥572.9m (FY, 2024) |
Gross profit | Gross profit $269.6m (FY, 2025) | Gross profit ¥976m (FY, 2025) | Gross profit ¥494m (FY, 2024) |
Net income | Net income ($175.5m) (FY, 2025) | Net income ¥361.3m (FY, 2025) | Net income (¥188.2m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 985m | Total funding raised N/A | Total funding raised $ 145.7m |

Amoy Diagnostics (AmoyDx, 厦门艾德生物医药科技股份有限公司) is a company that provides molecular diagnostic products and services for oncology precision medicine.
View company
Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications, primarily in genetic testing and oncology testing.
View company